For: | García-Compeán D, González-González JA, Lavalle-González FJ, González-Moreno EI, Villarreal-Pérez JZ, Maldonado-Garza HJ. Hepatogenous diabetes: Is it a neglected condition in chronic liver disease? World J Gastroenterol 2016; 22(10): 2869-2874 [PMID: 26973383 DOI: 10.3748/wjg.v22.i10.2869] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v22/i10/2869.htm |
Number | Citing Articles |
1 |
Manuela Maria de Lima Carvalhal, Jeane Lorena Lima Dias, Daniela Lopes Gomes, Juarez Antônio Simões Quaresma. Hepatitis C virus eradication on glycemic control and insulin resistance. Revista da Associação Médica Brasileira 2021; 67(12): 1821 doi: 10.1590/1806-9282.20210752
|
2 |
Abd Elkhalek Hamed, Nadia Elwan, Mervat Naguib, Reda Elwakil, Gamal Esmat, Mohamed El Kassas, Sherief Abd-Elsalam, Shorouk Moussa. Diabetes Association with Liver Diseases: An Overview for Clinicians. Endocrine, Metabolic & Immune Disorders - Drug Targets 2019; 19(3): 274 doi: 10.2174/1871530318666181116111945
|
3 |
Laura I. Coman, Oana A. Coman, Ioana A. Bădărău, Horia Păunescu, Mihai Ciocîrlan. Association between Liver Cirrhosis and Diabetes Mellitus: A Review on Hepatic Outcomes. Journal of Clinical Medicine 2021; 10(2): 262 doi: 10.3390/jcm10020262
|
4 |
Angelo Armandi, Chiara Rosso, Gian Paolo Caviglia, Elisabetta Bugianesi. Insulin Resistance across the Spectrum of Nonalcoholic Fatty Liver Disease. Metabolites 2021; 11(3): 155 doi: 10.3390/metabo11030155
|
5 |
Manisha Yadav, Smriti Verma, Purnima Tiwari, Madhav Nilakanth Mugale. Unraveling the mechanisms of hepatogenous diabetes and its therapeutic perspectives. Life Sciences 2024; 353: 122934 doi: 10.1016/j.lfs.2024.122934
|
6 |
Lung-Wen Tsai, Yi-Hsiang Lu, Rajni Dubey, Jeng-Fong Chiou, Ilias Migdalis. Reenvisioning Traditional to Regenerative Therapeutic Advances in Managing Nonalcoholic Fatty Liver Disease in Diabetes Mellitus. Journal of Diabetes Research 2021; 2021: 1 doi: 10.1155/2021/7692447
|
7 |
Anchalia Chandrakumaran, Mohammad Shadab Siddiqui. Implications of Nonalcoholic Steatohepatitis as the Cause of End-Stage Liver Disease Before and After Liver Transplant. Gastroenterology Clinics of North America 2020; 49(1): 165 doi: 10.1016/j.gtc.2019.09.005
|
8 |
Valeria Grancini, Irene Cogliati, Gianfranco Alicandro, Alessia Gaglio, Stefano Gatti, Maria Francesca Donato, Emanuela Orsi, Veronica Resi. Assessment of hepatic fibrosis with non-invasive indices in subjects with diabetes before and after liver transplantation. Frontiers in Endocrinology 2024; 15 doi: 10.3389/fendo.2024.1359960
|
9 |
Marco Infante, Nathalia Padilla, SriGita Madiraju, Ana Alvarez, David Baidal, Camillo Ricordi, Rodolfo Alejandro. Transplantation, Bioengineering, and Regeneration of the Endocrine Pancreas. 2020; : 439 doi: 10.1016/B978-0-12-814833-4.00037-X
|
10 |
Emanuela Orsi, Valeria Grancini, Stefano Menini, Alessio Aghemo, Giuseppe Pugliese. Hepatogenous diabetes: Is it time to separate it from type 2 diabetes?. Liver International 2017; 37(7): 950 doi: 10.1111/liv.13337
|
11 |
Mandeep Kumar Singh, Bhrigu Kumar Das, Sandeep Choudhary, Deepak Gupta, Umesh K Patil. Diabetes and hepatocellular carcinoma: A pathophysiological link and pharmacological management. Biomedicine & Pharmacotherapy 2018; 106: 991 doi: 10.1016/j.biopha.2018.06.095
|
12 |
Mona Mahmoud Hassouna, Mohammed Sayed Moustafa, Mona Hamdy, Eman Abdelsameea, Mohamed Abbasy, Mary Naguib. Study of transcription factor 7-like 2 (TCF7L2) gene polymorphism in cirrhotic patients with diabetes. Egyptian Liver Journal 2023; 13(1) doi: 10.1186/s43066-023-00285-5
|
13 |
Farzana Shafqat, Muhammad Naeem A. Khan, Sarah Shafqat. IoT in Healthcare and Ambient Assisted Living. Studies in Computational Intelligence 2021; 933: 43 doi: 10.1007/978-981-15-9897-5_3
|
14 |
Doaa I. Mohamed, Enas S. Nabih, Dalia A.A. El-Waseef, Omnyah A. El-Kharashi, Abeer A. Abd El Samad. The protective effect of pentoxifylline versus silymarin on the pancreas through increasing adenosine by CD39 in a rat model of liver cirrhosis: Pharmacological, biochemical and histological study. Gene 2018; 651: 9 doi: 10.1016/j.gene.2018.02.001
|
15 |
Jiang Zhang, Julia Schewe, Hanwei Li, Marie-Christine Makeschin, Ujjwal M. Mahajan, Alexander L. Gerbes, Christian J. Steib. The effects of hepatic steatosis on thromboxane A2 induced portal hypertension. Gastroenterología y Hepatología 2019; 42(9): 534 doi: 10.1016/j.gastrohep.2019.03.015
|
16 |
Valeria Grancini, Veronica Resi, Eva Palmieri, Giuseppe Pugliese, Emanuela Orsi. Management of diabetes mellitus in patients undergoing liver transplantation. Pharmacological Research 2019; 141: 556 doi: 10.1016/j.phrs.2019.01.042
|
17 |
Shuwen Zhong, Zhaohui Deng, Lirong Jiang, Jingqing Zeng, Tingting Yu. Wilson’s Disease with Hepatogenous Diabetes: A Case Report. Iranian Journal of Pediatrics 2021; 31(2) doi: 10.5812/ijp.105261
|
18 |
Diego García-Compeán, Emanuela Orsi, Ramesh Kumar, Felix Gundling, Tsutomu Nishida, Jesús Zacarías Villarreal-Pérez, Ángel N Del Cueto-Aguilera, José A González-González, Giuseppe Pugliese. Clinical implications of diabetes in chronic liver disease: Diagnosis, outcomes and management, current and future perspectives. World Journal of Gastroenterology 2022; 28(8): 775-793 doi: 10.3748/wjg.v28.i8.775
|
19 |
Yasmin Saad, Abobakr Awad, Wafaa Alakel, Wahid Doss, Tahany Awad, Mahasen Mabrouk. Data mining of routine laboratory tests can predict liver disease progression in Egyptian diabetic patients with hepatitis C virus (G4) infection: a cohort study of 71 806 patients. European Journal of Gastroenterology & Hepatology 2018; 30(2): 201 doi: 10.1097/MEG.0000000000001008
|
20 |
Valeria Grancini, Maddalena Trombetta, Maria Elena Lunati, Maria Linda Boselli, Stefano Gatti, Maria Francesca Donato, Eva Palmieri, Veronica Resi, Giuseppe Pugliese, Riccardo C. Bonadonna, Emanuela Orsi. Central role of the β-cell in driving regression of diabetes after liver transplantation in cirrhotic patients. Journal of Hepatology 2019; 70(5): 954 doi: 10.1016/j.jhep.2019.01.015
|
21 |
Preetam Nath, Anil C. Anand. Hepatogenous Diabetes: A Primer. Journal of Clinical and Experimental Hepatology 2021; 11(5): 603 doi: 10.1016/j.jceh.2021.04.012
|
22 |
Jiang Zhang, Julia Schewe, Hanwei Li, Marie-Christine Makeschin, Ujjwal M. Mahajan, Alexander L. Gerbes, Christian J. Steib. The effects of hepatic steatosis on thromboxane A2 induced portal hypertension. Gastroenterología y Hepatología (English Edition) 2019; 42(9): 534 doi: 10.1016/j.gastre.2019.03.021
|
23 |
Praveen Vasepalli, Mohd T. Noor, Bhagwan S. Thakur. Hepatogenous Diabetes - A Report from Central India. Journal of Clinical and Experimental Hepatology 2022; 12(2): 312 doi: 10.1016/j.jceh.2021.08.018
|
24 |
Azam Eshaghian, Ameneh Khodarahmi, Fatemeh Safari, Fariba Binesh, Ali Moradi. Curcumin attenuates hepatic fibrosis and insulin resistance induced by bile duct ligation in rats. British Journal of Nutrition 2018; 120(4): 393 doi: 10.1017/S0007114518001095
|
25 |
Yingying Zhao, Huichun Xing. A Different Perspective for Management of Diabetes Mellitus: Controlling Viral Liver Diseases. Journal of Diabetes Research 2017; 2017: 1 doi: 10.1155/2017/5625371
|
26 |
Abd Elkhalek Hamed, Medhat Elsahar, Nadia M. Elwan, Sarah El-Nakeep, Mervat Naguib, Hanan Hamed Soliman, Ashraf Ahmed Aboubakr, Amany AbdelMaqsod, Heba Sedrak, Samir N. Assaad, Reda Elwakil, Gamal Esmat, Samira Salh, Taymour Mostafa, Sherif Mogawer, Sameh Emil Sadek, Maha M. Saber, Hanan Ezelarab, Asem Ashraf Mahmoud, Souad Sultan, Mohamed El Kassas, Ehab Kamal, Naglaa M. ElSayed, Shorouk moussa. Managing diabetes and liver disease association. Arab Journal of Gastroenterology 2018; 19(4): 166 doi: 10.1016/j.ajg.2018.08.003
|
27 |
Felix Gundling. Der hepatogene Diabetes – aktueller Stand der Diagnostik und Therapie. Journal für Klinische Endokrinologie und Stoffwechsel 2022; 15(2): 42 doi: 10.1007/s41969-022-00158-z
|
28 |
Ramesh Kumar, Diego García-Compeán, Tanmoy Maji. Hepatogenous diabetes: Knowledge, evidence, and skepticism. World Journal of Hepatology 2022; 14(7): 1291-1306 doi: 10.4254/wjh.v14.i7.1291
|